Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Fecal microbiota transplantation (FMT) has achieved satisfactory results in preventing the
recurrence of Clostridioides difficile infection, but these positive outcomes have only been …
recurrence of Clostridioides difficile infection, but these positive outcomes have only been …
The role of Th17 cells in inflammatory bowel disease and the research progress
L Chen, G Ruan, Y Cheng, A Yi, D Chen… - Frontiers in …, 2023 - frontiersin.org
Th17 cells play an important role in the abnormal immune response in inflammatory bowel
disease (IBD) and are involved in the development and progression of inflammation and …
disease (IBD) and are involved in the development and progression of inflammation and …
Fecal transplantation for treatment of inflammatory bowel disease
Background Inflammatory bowel disease (IBD) is a chronic, relapsing disease of the
gastrointestinal (GI) tract that is thought to be associated with a complex interplay between …
gastrointestinal (GI) tract that is thought to be associated with a complex interplay between …
Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract
AC Fenneman, M Weidner, LA Chen… - Nature Reviews …, 2023 - nature.com
Antibiotic use is increasing worldwide. However, the use of antibiotics is clearly associated
with changes in gut microbiome composition and function, and perturbations have been …
with changes in gut microbiome composition and function, and perturbations have been …
Fecal microbiota transplantation as new therapeutic avenue for human diseases
M Biazzo, G Deidda - Journal of Clinical Medicine, 2022 - mdpi.com
The human body is home to a variety of micro-organisms. Most of these microbial
communities reside in the gut and are referred to as gut microbiota. Over the last decades …
communities reside in the gut and are referred to as gut microbiota. Over the last decades …
Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases
Y Wang, S Zhang, TJ Borody, F Zhang - Chinese Medical Journal, 2022 - journals.lww.com
Fecal microbiota transplantation (FMT) has been used as a core therapy for treating
dysbiosis-related diseases by remodeling gut microbiota. The methodology and technology …
dysbiosis-related diseases by remodeling gut microbiota. The methodology and technology …
Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation
Gut dysbiosis has been associated with inflammatory bowel disease (IBD), one of the most
common gastrointestinal diseases. The microbial communities play essential roles in host …
common gastrointestinal diseases. The microbial communities play essential roles in host …
Efficacy of fecal microbiota transplantation in the treatment of active ulcerative colitis: a systematic review and meta-analysis of double-blind randomized controlled …
Background Fecal microbiota transplantation (FMT) has been investigated as a treatment
option for patients with inflammatory bowel disease with controversial results. We sought to …
option for patients with inflammatory bowel disease with controversial results. We sought to …
Crosstalk between the gut microbiota and postmenopausal osteoporosis: Mechanisms and applications
Q Xu, D Li, J Chen, J Yang, J Yan, Y Xia… - International …, 2022 - Elsevier
Postmenopausal osteoporosis (PMO) results from a reduction in bone mass and
microarchitectural deterioration in bone tissue due to estrogen deficiency, which may …
microarchitectural deterioration in bone tissue due to estrogen deficiency, which may …
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
Background Faecal microbiota transplantation (FMT) delivered via colonoscopic infusion or
enemas have been shown to induce remission in a proportion of patients with active …
enemas have been shown to induce remission in a proportion of patients with active …